搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
3 小时
Imbrium Therapeutics Announces Results of a Sunobinop Phase 1b Study in Patients With ...
Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...
来自MSN
23 小时
Urinary Incontinence: What a Doctor Wants You to Know
Urinary incontinence, or leakage of urine, is a very common condition for women of all ages, ethnicities and backgrounds.
Masala
3 天
Men’s Health Alert! Here’s how winter is impacting prostate health and triggers urinary ...
Discover how cold weather can trigger prostate problems in men over 60, including frequent urination, hormonal changes, and ...
3 天
How to end the tyranny of an overactive bladder: Amid concern over the dementia risk of a ...
Millions of people with overactive bladder syndrome are prescribed daily anticholinergics. But research has linked these ...
4 天
on MSN
Winter and risk of prostate problems in men over 60: What’s the connection? Urologist ...
Cold weather can trigger frequent urination, hormonal changes and diuresis, especially in men over the age of 60.
4 天
FDA approves Gemtesa for overactive bladder in men with benign prostatic hyperplasia
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
healthday
4 天
FDA Approves Gemtesa for Overactive Bladder in Men With BPH
Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈